Folic acid and vitamin B12 supplementation attenuates isoprenaline-induced myocardial infarction in experimental hyperhomocysteinemic rats

Pharmacological Research

Volumn 46, Issue 3, 2002, Pages 213-219

  Hagar, Hanan H ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Folic acid; Hyperhomocysteinemia; Isoprenaline; Lipid peroxidation; Myocardial infarction; Rats; Vitamin B12

Indexed keywords

CREATINE KINASE; CYANOCOBALAMIN; DRINKING WATER; FOLIC ACID; GLUTATHIONE; ISOPRENALINE; LACTATE DEHYDROGENASE; MALONALDEHYDE; METHIONINE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DRUG EFFECT; ELECTROCARDIOGRAPHY; ENZYME BLOOD LEVEL; HEART INFARCTION; HEART RATE; HEMODYNAMICS; HISTOPATHOLOGY; HYPERHOMOCYSTEINEMIA; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; ST SEGMENT ELEVATION; VITAMIN SUPPLEMENTATION;

EID: 0036421410     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-6618(02)00095-6     Document Type: Article

References (53)

1. Selhub J, Miller JW. The pathogenesis of homocysteinemia: Interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine. Am J Clin Nutr 1992; 55: 131-8.
2. Mayer EL, Jacobsen DW, Robinson K. Homocysteine and coronary atherosclerosis. J Am Coll Cardiol 1996; 27: 517-27.
3. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA 1995; 274: 1049-57.
4. Stubbs PJ, Alobaidi MK, Conroy RM, Mus B, Collinson PO, Path-Graham IM, Frepi-Noble MI. Effect of plasma homocysteine concentration on early and late events in patients with acute coronary syndromes. Circulation 2000; 102(6Z): 605-10.
5. Senaratne MP, Griffiths J, Nagendran J. Elevation of plasma homocysteine levels associated with acute myocardial infarction. Clin Invest Med 2000; 23(4): 220-6.
6. Qujeq D, Omran TS, Hosini L. Correlation between total homocysteine, low-density lipoprotein cholesterol and high density lipoprotein cholesterol in the serum of patients with myocardial infarction. Clin Biochem 2001; 34(2): 97-101.
7. El Kossi MM, Zakhhary MM. Oxidative stress in the context of acute cerebrovascular stroke. Stroke 2000; 31(8): 1889-92.
8. Markis M. Homocysteinemia and thrombosis. Clin Lab Haematol 2000; 22(3): 133-43.
9. 12 and folate. Am J Epidemiol 1996; 143(9): 845-59.
10. Wilcken DE, Wang XL, Adachi T, Hara H, Durate N, Green K, Wilcken B. Relationship between homocysteine and superoxide dis-mutase in homocystinuria: Possible relevance to cardiovascular risk. Arterioscler Thromb Vasc Biol 2000; 20(5): 1199-2202.
11. Gulec S, Aras O, Akar E, Tutar E, Omurlu K, Avci F, Dincer I, Akar N, Oral D. Methylenetetrahydrofolate reductase gene polymorphism and risk of premature myocardial infarction. Clin Cardiol 2001; 24(4): 281-4.
12. Celermajer DS, Sorensen K, Ryalls M, Robinson J, Thomas O, Leonard JV, Deanfield JE. Impaired function occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parents. J Am Coll Cardiol 1993; 22: 854-8.
13. Bots ML, Launer LJ, Lindemans J, Hofman A, Grobbee DE. Homocysteine, atherosclerosis and prevalent cardiovascular disease in the elderly: The Rotterdam study. J Intern Med 1997; 242(4): 339-47.
14. Aronow WS, Ahn C. Increased plasma homocysteine is an independent predictor of new coronary events in older persons. Am J Cardiol 2000; 86(3): 346-7.
15. Henning BF, Rieezler R, Tepel M, Langer K, Raidt H, Graefe U, Zidek W. Evidence of altered homocysteine metabolism in chronic renal failure. Nephron 1999; 83: 314-22.
16. Stamler JS, Osborn JA, Jaraji O, Rabbani LE, Mullins M, Singel D, Loscalzo J. Adverse effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest 1993; 91: 308-18.
17. Lentz SR, Sobey CG, Piegors DJ, Bhopatkar MY, Faraci FM, Malinow MR, Heistad DD. Vascular dysfunction in monkeys with diet-induced hyperhomocysteinemia. J Clin Invest 1996; 98: 24-9.
18. Woo KS, Chook P, Lolin YI, Cheung ASP, Chan LT, Sun YY, Sanderson JE, Metrewell C, Celermajer DS. Hyperhomocysteinemia is a risk factor for arterial endothelial dysfunction in humans. Circulation 1997; 96: 2542-4.
19. Brattstrom L. Vitamins as homocysteine lowering agents. J Nutr 1996; 126: 1276S-80S.
20. Nirmala C, Puvanakrishnan R. Isoproterenol induced myocardial infarction in rats: Functional and biochemical alteration. Med Sci Res 1994; 22: 575-7.
21. Singal PK, Kapur N, Dhillon KS, Beamish RE, Dhalla NS. Role of free radicals in catecholamine induced cardiomyopathy. Can J Physiol Pharmacol 1982; 60: 1390-7.
22. Ungvari Z, Pacher P, Rischak K, Szollar L, Koller A. Dysfunction of nitric oxide mediation in isolated rat arterioles with methionine diet-induced hyperhomocysteinemia. Arterioscler Thromb Vasc Biol 1999; 19(8): 1899-904.
23. Ungvari Z, Sarkadi-Nagy E, Bagi Z, Szollar L, Koller A. Simultaneously increased TxA(2) activity in isolated arterioles and platelets of rats with hyperhomocysteinemia. Arterioscler Thromb Vasc Biol 2000; 20(5): 1203-8.
24. Murohara DJ, Ikeda H, Sasaki K, Shintani S, Akita T, Shimada T, Imaizumi T. Hyperhomocysteinemia impairs angiogenesis in response to hindlimb ischemia. Arterioscler Thromb Vasc Biol 2000; 20(12): 2579-85.
25. Chauveau P, Chadefaux B, Coude M, Aupetit J, Kamoun P, Jungers P. Long-term folic acid supplementation (but not pyridoxine) lowers elevated plasma homocysteine level in chronic renal failure. Miner Electrolyte Metab 1996; 22(1-3): 106-9.
26. 12 administration on endothelial dysfunction induced by post-methionine load hyperhomocysteinemia. Am J Cardiol 1999; 84: 1359-61.
27. Wroblewski F, LaDue JS. Lactate dehydrogenase activity in the blood. Proc Soc Exp Biol Med 1955; 90: 210.
28. Stein EA. Textbook of clinical chemistry. In: Tietz NW, ed. Philadelphia: Saunders, 1986: 879-86.
29. Buege JA, Aust SD. Microsomal lipid peroxidation methods. Enzymology 1978; 52: 302-10.
30. Ellman G. Tissue sulfhydryl groups. Arch Biochem Biophys 1959; 82: 70-6.
31. Nagi MN, Suneja SK, Cook L. Depletion of rat hepatic glutathione and inhibition of microsomal trans-2 enoyl-CoA reductase activity following admininstration of dec-2-ynol and dec-2-ynoic acid. Arch Biochem Biophys 1992; 293: 71-87.
32. Armitage P. Statistical methods in medical research. 3rd edn. Oxford: Blackwell, 1974: 116-12.
33. Giles WH, Croft JB, Greenlund KJ, Ford ES, Kittner SJ. Association between total homocysteine and the likelihood for a history of acute myocardial infarction and ethnicity: Results from the third national health and nutrition examination survey. Am Heart J 2000; 139: 446-53.
34. Emsley AM, Jeremy JY, Gomes GN, Angelini GD, Plane F. Investigation of the inhibitory effects of homocysteine and copper on nitric-oxide mediated relaxation of rat isolated aorta. Br J Pharmacol 1999; 126(4): 1034-40.
35. Lang D, Kredan MB, Moat SJ, Hussain SA, Powell CA, Bellamy MF. Homocysteine-induced inhibition of endothelium-dependent relaxation in rabbit aorta: Role for superoxide anions. Arterioscler Thromb Vasc Biol 2000; 20(2): 422-7.
36. Nishio E, Watanabe Y. Homocysteine as a modulator of platelet-derived growth factor action in vascular smooth muscle cells: A possible role for hydrogen peroxide. Br J Pharmacol 1997; 122(2): 269-74.
37. Blom HJ. Lipid peroxidation and susceptibility of low density lipoprotein to in vitro oxidation in hyperhomocysteinemia. Eur J Clin Invest 1995; 25: 149-54.
38. Liao JK, Shin WS, Lee WY, Clark SL. Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J Biol Chem 1995; 270: 319-24.
39. Quere I, Habib A, Tobelem G, Maclouf J. Inhibition of cyclooxygenase activity in human endothelial cells by homocysteine. Adv Prostag Throm Leuk Res 1995; 23: 397-9.
40. Khajuria A, Houston DS. Induction of monocyte tissue factor expression by homocysteine: A possible mechanism for thrombosis. Blood 2000; 96(3): 966-72.
41. Jones BG, Rose FA, Tudball N. Lipid peroxidation and homocysteine induced toxicity. Atherosclerosis 1994; 105: 165-70.
42. Toborek M, Kopieczna-Grzebieniak E, Drozdz M, Wieczorek M. Increase lipid peroxidation as a mechanism of methionine-induced atherosclerosis in rabbits. Atherosclerosis 1995; 115(2): 217-24.
43. Hultberg B, Andersson A, Isaksson A. The cell damaging effects of low amounts of homocysteine and copper ions in human cell line cultures are caused by oxidative stress. Toxicology 1997; 123: 33-40.
44. Huang RF, Hsu YC, Lin HL, Yang FL. Folate depletion and elevated plasma homocysteine promote oxidative stress in rat livers. J Nutr 2001; 131(1): 33-8.
45. Holven KB, Holm T, Aukrust P, Christensen B, Kjekshus J, Andreassen A, Gullestad K. Effect of folic acid treatment on endothelium-dependent vasodilation and nitric oxide-derived end products in hyperhomocysteinemic subjects. Am J Med 2001; 110(7): 536-42.
46. Usui M, Matsuoka H, Miyazaki H, Ueda S, Okuda S, Imaizumi T. Endothelial dysfunction by acute hyperhomocysteinemia: Restoration by folic acid. Clin Sci 1999; 96: 229-35.
47. Arnadottir M, Brattstrom L, Simonsen O, Thysell H, Hultberg B, Andersson A. The effect of high dose pyridoxine and folic acid supplemetation on serum lipids and plasma homocysteine concentration in dialysis patients. Clin Nephrol 1993; 40: 236-40.
48. Brattstrom L, Israelsson B, Norrving B, Bergqvist D, Thorne J, Hultberg B. Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease, effects of pyridoxine and folic acid treatment. Atherosclerosis 1990; 81: 51-60.
49. Wilmink W, Stroes ESG, Erkelens WD. Influence of folic acid on postprandial endothelial dysfunction. Arterioscler Thromb Vasc Biol 2000; 20: 185-8.
50. Verhaar MC, Wever RM, Kastelein JJ. Effects of folic acid supplementation on endothelial function in familial hypercholesterolemia. A randomized placebo-controlled trial. Circulation 1999; 100: 335-8.
51. Joshi R, Adhikari S, Patro BS, Chattopadhyay S, Mukherjee T. Free radical scavenging behaviour of folic acid evidence for possible antioxidant activity. Free Radic Biol Med 2001; 30(12): 1390-9.
52. Ubbink JB, Vermaak WJH, Van-Der-Merwe A, Becker PJ, Delport R, Potgieter HC. Vitamin requirements for the treatment of hyperhomocysteinemia in humans. J Nutr 1994; 124: 1927-33.
53. Brattstrom L, Israelsson B, Jeppson JO, Hultberg B. Folic acid - An innocuous means of reducing plasma homocysteine. Scand J Clin Lab Invest 1988; 48: 215-21.